Cited by 481Pluripotent Stem Cells ResearchMuscle Physiology and DisordersMesenchymal stem cell research

Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice

Open access
Darabi, Radbod, Arpke, Robert W., Irion, Stefan, Dimos, John T., Grskovic, Marica, Kyba, Michael, Perlingeiro, Rita C.R.·2012·Cell Stem Cell

Abstract

A major obstacle in the application of cell-based therapies for the treatment of neuromuscular disorders is obtaining the appropriate number of stem/progenitor cells to produce effective engraftment. The use of embryonic stem (ES) or induced pluripotent stem (iPS) cells could overcome this hurdle. However, to date, derivation of engraftable skeletal muscle precursors that can restore muscle function from human pluripotent cells has not been achieved. Here we applied conditional expression of PAX7 in human ES/iPS cells to successfully derive large quantities of myogenic precursors, which, upon transplantation into dystrophic muscle, are able to engraft efficiently, producing abundant human-derived DYSTROPHIN-positive myofibers that exhibit superior strength. Importantly, transplanted cells also seed the muscle satellite cell compartment, and engraftment is present over 11 months posttransplant. This study provides the proof of principle for the derivation of functional skeletal myogenic progenitors from human ES/iPS cells and highlights their potential for future therapeutic application in muscular dystrophies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2012.02.015

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Human pluripotent stem cells induced to express PAX7 and treated with defined chemical cocktails yield transplantable muscle progenitors that refill the satellite cell niche and maintain dystrophin-positive fibers in dystrophin-deficient mice.

    “Induced expression of PAX7 and exposure to defined chemical cocktails145–147 in human pluripotent stem cells has been shown to generate engraftable muscle progenitor cells that replenish the satellite cell compartment and sustain formation of dystrophin-positive myofibers in dystrophin-deficient mice145,147.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Darabi, R., Arpke, R. W., Irion, S., Dimos, J. T., Grskovic, M., Kyba, M., & Perlingeiro, R. C. R.
Affiliations
University of Minnesota (US)
Corresponding author
Perlingeiro, Rita C.R.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2012-05
Volume
10
Issue
5
Pages
610-619
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W1990897270
Cited by
481
References
45
Citations by year
2026: 12 · 2025: 19 · 2024: 26 · 2023: 28 · 2022: 40 · 2021: 33 · 2020: 38 · 2019: 40 · 2018: 38 · 2017: 32 · 2016: 35 · 2015: 44 · 2014: 42 · 2013: 34 · 2012: 19
FWCI
17.86
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Aging (R21AG034370)
  • National Institute of General Medical Sciences (P01GM081627)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR055299, RC1AR058118, RC2AR058919, R01AR055685)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
myogenic progenitor cells, embryonic stem cells, induced pluripotent stem cells, Duchenne muscular dystrophy, dystrophin, Pax7, skeletal muscle regeneration, cell transplantation, engraftment, satellite cells, muscle contractility, cell therapy, neuromuscular disorders
MeSH terms
Animals, Feasibility Studies, Humans, Muscle Contraction, Muscular Dystrophies, Transplantation, Heterologous, Dystrophin, Mice, Inbred mdx, Satellite Cells, Skeletal Muscle, Stem Cell Transplantation, Cell Proliferation, Mice, PAX7 Transcription Factor, Embryonic Stem Cells, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review